Testing effectiveness (Phase 2)Ended earlyNCT00904423What this trial is testingPh I/II of Vitamin D on Bone Mineral Density & Markers of Bone ResorptionWho this might be right forBreast CancerBone Diseases Mark Pegram 8
Not applicableLooking for participantsNCT06282796What this trial is testingEarly Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer ChemotherapyWho this might be right forBreast Cancer First Hospital of China Medical University 600
Not applicableStudy completedNCT00146588What this trial is testingCytoxan, Epirubicin and Capecitabine in Women With Breast CancerWho this might be right forBreast CancerStage I Breast CancerStage II Breast Cancer+1 more Craig A. Bunnell, MD, MPH 55
Testing effectiveness (Phase 2)UnknownNCT05044988What this trial is testingHS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast CancerWho this might be right forHR+/HER2- Advanced and/or Metastatic Breast Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Not Yet RecruitingNCT07828288What this trial is testingBeyond Psychological Distress: Implementation of a Dyadic Behavioral Intervention Targeting Neuroendocrine and mRNA Translational Pathways in Late-Stage Breast CancerWho this might be right forCASA InterventionUsual Care Ponce Medical School Foundation, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT01205503What this trial is testingTrial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) ReleaseWho this might be right forBreast CancerNon-Hodgkin's Lymphoma Mara Chambers 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06172127What this trial is testingPHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast CancerWho this might be right forHER2-positive Breast Cancer MedSIR 165
Testing effectiveness (Phase 2)Looking for participantsNCT06516289What this trial is testingNeoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± CamrelizumabWho this might be right forBRCA-Mutated Breast CarcinomaHER2-negative Breast Cancer Fudan University 130
Testing effectiveness (Phase 2)Looking for participantsNCT06254690What this trial is testingThe Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical StudyWho this might be right forBreast Cancer The First Affiliated Hospital with Nanjing Medical University 102
Large-scale testing (Phase 3)Study completedNCT00003013What this trial is testingChemotherapy Plus Surgery in Treating Women With Breast CancerWho this might be right forBreast Cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 450
Large-scale testing (Phase 3)Study completedNCT03337724What this trial is testingIpatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 579
Not applicableLooking for participantsNCT05189496What this trial is testingHyperbaric Oxygen in the Prevention of Radiation PneumonitisWho this might be right forRadiation Pneumonitis Guangdong Provincial People's Hospital 380
Not applicableUnknownNCT02327442What this trial is testing68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer PatientsWho this might be right forGliomaBreast Cancer Xijing Hospital 46
Not applicableStudy completedNCT00922961What this trial is testingResearch for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast CancerWho this might be right forBreast Cancer Centre Oscar Lambret 25
Not applicableUnknownNCT00331942What this trial is testingBreast Cancer Associated AntibodiesWho this might be right forBreast Cancer Lab Discoveries Ltd. 100
Not applicableStudy completedNCT01084642What this trial is testingFemale Cancer Patients' Preference For Sexual Health InterventionsWho this might be right forBreast CancerGynecologic Cancer Memorial Sloan Kettering Cancer Center 229
Not applicableUnknownNCT04208074What this trial is testingExercise Study for Breast Cancer SurvivorsWho this might be right forBreast Cancer San Diego Biomedical Research Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT06327490What this trial is testingA Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast CancerWho this might be right forBreast Cancer University of Florida 30
Large-scale testing (Phase 3)UnknownNCT03500380What this trial is testingRC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesWho this might be right forBreast NeoplasmsBreast DiseasesCapecitabine+3 more RemeGen Co., Ltd. 301
Not applicableUnknownNCT05892380What this trial is testingThe Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast LessionsWho this might be right forBreast Cancer Fudan University 800